Filing Details
- Accession Number:
- 0001140361-10-024899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-09 13:00:00
- Reporting Period:
- 2010-06-06
- Filing Date:
- 2010-06-09
- Accepted Time:
- 2010-06-09 16:59:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1401782 | Mark Wood | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Vp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-06 | 1,250 | $0.00 | 14,085 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-06-07 | 1,000 | $0.00 | 15,085 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-06-08 | 470 | $18.87 | 14,615 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2010-06-06 | 1,250 | $0.00 | 1,250 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2010-06-06 | 1,000 | $0.00 | 1,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,500 | 2010-06-06 | No | 4 | M | Direct | |
| 3,500 | 2010-06-07 | No | 4 | M | Direct |
Footnotes
- Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.
- Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.
- Transaction made pursuant to a Rule 10b5-1 Trading Plan executed on September 2, 2009.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $18.76 to $18.95. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original grant of restricted stock units vest 1/4th each on July 7, 2009, June 6, 2010, June 6, 2011, and June 6, 2012.
- Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.
Billionaire Hedge Funds
